WallStSmart
XTLB

XTL Biopharmaceuticals Ltd ADR

NASDAQ: XTLB · HEALTHCARE · BIOTECHNOLOGY

$3.90
+9.55% today

Updated 2026-04-30

Market cap
$5.65M
P/E ratio
P/S ratio
5.84x
EPS (TTM)
$-3.60
Dividend yield
52W range
$2 – $10
Volume
2.3M

XTL Biopharmaceuticals Ltd ADR (XTLB) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Revenue$3.20M$454000.00$907000.00$5.94M$938000.00$2.37M$41000.00$-6000.00$23000.00$29000.00$52000.00$69000.00$28000.00$1.47M$-459000.00$0.00$451000.00
Revenue growth (YoY)-85.8%+99.8%+554.9%-100.0%+152.6%-98.3%-114.6%+483.3%+26.1%+79.3%+32.7%-59.4%+5135.7%-131.3%+100.0%
Cost of revenue$2.80M$54000.00$110000.00$-5.63M$380000.00$741000.00$17.00$7000.00$3000.00$1000.00$0.00$1000.00$1000.00$1000.00$0.00$448000.00
Gross profit$400000.00$400000.00$797000.00$5.94M$558000.00$1.63M$-17.00$-13000.00$20000.00$28000.00$52000.00$69000.00$-1000.00$-1000.00$-1000.00$0.00$3000.00
Gross margin12.5%88.1%87.9%100.0%59.5%68.7%-0.0%216.7%87.0%96.6%100.0%100.0%-3.6%-0.1%0.2%0.7%
R&D$7.54M$10.87M$20.95M$10.39M$64000.00$158000.00$99000.00$113000.00$278000.00$578000.00$443000.00$43000.00$38000.00$35000.00$38000.00$30000.00$30000.00$31000.00$98000.00
SG&A$5.46M$5.58M$5.58M$5.14M$2.43M$1.22M$1.08M$2.70M$1.98M$1.72M$1.41M$1.26M$1.19M$755000.00$807000.00$910000.00$1.00M$850000.00$734000.00$1.87M
Operating income$-14.38M$-16.05M$-25.73M$-9.59M$2.57M$-1.26M$-1.16M$-2.36M$-2.89M$-2.02M$-3.61M$-2.56M$-1.25M$-793000.00$-842000.00$-948000.00$-1.03M$-880000.00$-765000.00$-2.17M
Operating margin-449.8%-3534.4%-2837.4%-161.5%-251.2%-122.2%-4931.7%60183.3%-11134.8%-4296.6%-1525.0%-1220.3%-3385.7%-70.3%191.7%-481.6%
EBITDA$-12.36M$-15.80M$-25.63M$-18.40M$2.58M$-1.21M$-1.06M$-3.80M$-1.10M$-1.97M$-2.00M$-1.71M$-1.25M$-792000.00$-268000.00$-947000.00$-1.03M$-879000.00$-764000.00$-930000.00
EBITDA margin-386.5%-3480.8%-2825.5%-309.8%-404.7%-46.3%-4802.4%33333.3%-7434.8%-4293.1%-1523.1%-388.4%-3382.1%-70.3%191.5%-206.2%
EBIT$-12.60M$-16.05M$-25.73M$-18.44M$2.57M$-1.25M$-1.16M$-3.93M$-1.41M$-2.02M$-2.01M$-1.71M$-1.25M$-793000.00$-439860.00$-948000.00$-1.03M$-880000.00$-765000.00$-1.13M
Interest expense$0.00$0.00$4000.00$3000.00$2000.00$7000.00$8000.00$15000.00$35000.00$6000.00$11000.00$16000.00$8000.00$7000.00$29000.00$16999.00$21000.00$10999.00$3999.00$86000.00
Income tax$78000.00$227000.00$-206000.00$-31000.00$-23000.00$-1.26M$6000.00$-1.19M$458000.00$505000.00$2.31M$832000.00$-457000.00$-80000.00$-69000.00$-166000.00$-1.47M$468000.00$-167894.00$-130000.00
Effective tax rate-0.6%-1.5%0.8%0.3%-0.9%50.0%-0.5%46.0%-22.7%-25.0%-115.9%-48.6%36.9%-2.8%4.9%17.5%142.2%-53.2%98.9%11.2%
Net income$-14.02M$-15.13M$-24.94M$-9.25M$2.59M$-1.26M$-1.21M$-1.39M$-2.48M$-2.53M$-4.31M$-2.54M$-781000.00$2.99M$-1.35M$-782000.00$435000.00$-1.35M$-1782.00$-1.03M
Net income growth (YoY)-8.0%-64.8%+62.9%+128.0%-148.6%+4.0%-15.2%-78.1%-2.1%-70.6%+41.0%+69.3%+482.3%-145.1%+41.9%+155.6%-409.9%+99.9%-57531.9%
Profit margin-438.4%-3333.0%-2749.6%-155.7%-148.2%-104.5%-6163.4%71850.0%-11065.2%-2693.1%5742.3%-1952.2%-2792.9%29.7%293.7%-227.7%